50 results
8-K
EX-10.2
FRTX
Fresh Tracks Therapeutics, Inc.
10 Oct 23
Departure of Directors or Certain Officers
4:49pm
. Upon termination of Consultant's engagement with Corporation under this Agreement, Consultant promptly will return all Confidential Information … , patented or unpatented, that Consultant made prior to engagement by Corporation hereunder are excluded from the scope of this Agreement. Consultant
8-K
EX-10.2
lm8fweg54
3 May 22
Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals
4:08pm
8-K
EX-1.1
3huqnqrirzz6vy gvb
22 Jul 21
Brickell Biotech Announces $5.0 Million Bought Deal Offering of Common Stock
4:08pm
8-K
EX-10.2
gv3 981i8stsddgn2o
24 Nov 20
Departure of Directors or Certain Officers
8:06am